alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 32.2**

 

**CERTIFICATION OF PRINCIPAL**

**FINANCIAL OFFICER PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT BY**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with this Annual Report of Caspian Services, Inc. (the “Company”) on Form 10-K/A-1 for the year ended September 30, 2008, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Baile, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 

 

|   | (1) | The Report fully complies with the requirements of section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------|

 

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------|

 

| Date: January 15, 2009 | By     | /s/ John Baile                      |
|------------------------|--------|-------------------------------------|
|                   |   | John Baile, Chief Financial Officer |
<TABLE> <S> <C>

<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>               DEC-31-2000
<PERIOD-START>                  JAN-01-2000
<PERIOD-END>                    MAR-31-2000
<CASH>                          789
<SECURITIES>                    0
<RECEIVABLES>                   1,182
<ALLOWANCES>                    0
<INVENTORY>                     13,812
<CURRENT-ASSETS>                16,682
<PP&E>                          95,662
<DEPRECIATION>                  88,685
<TOTAL-ASSETS>                  23,659
<CURRENT-LIABILITIES>           919,320
<BONDS>                         0
<PREFERRED-MANDATORY>           0
<PREFERRED>                     0
<COMMON>                        92,076
<OTHER-SE>                      (1,030,802)
<TOTAL-LIABILITY-AND-EQUITY>    23,659
<SALES>                         21,903
<TOTAL-REVENUES>                21,903
<CGS>                           9,905
<TOTAL-COSTS>                   78,615
<OTHER-EXPENSES>                229,686
<LOSS-PROVISION>                0
<INTEREST-EXPENSE>              15,794
<INCOME-PRETAX>                 (312,097)
<INCOME-TAX>                    0
<INCOME-CONTINUING>             (312,097)
<DISCONTINUED>                  0
<EXTRAORDINARY>                 0
<CHANGES>                       0
<NET-INCOME>                    (312,097)
<EPS-BASIC>                     (.00)
<EPS-DILUTED>                   (.00)







</TABLE>
#### The State *v.*Atkins.

An indictment for passing a counterfeit bank-note, &c. must profess to set out, not the effect, purport, or substance only of the note, but an exact copy of it.

*Wednesday, December*2.

ERROR to the *Noble*Circuit Court.

' *W. J. Peaslee,*for the state.

*D. H. Colerich*and *W. H.*Coombs, for the defendant.

Dewey, J.

This was a prosecution for passing counterfeit bank-bills as true, knowing them to be false. The indictment contains three counts. In two of thena the false bill is alleged to be “ of the following purport and effect, to wit,” &c.; and in the other, to be “ of the following purport, to wit,” &c. Plea, not guilty, jury trial, and verdict of conviction; judgment arrested by the Court and the prisoner discharged.

We concur in the decision of the Circuit Court arresting the judgment. In cases of forgery, or of knowingly uttering counterfeited instruments of writing, the indictment must profess to set out an exact copy of the counterfeit, that the Court may see it is one of those instruments, the false making or passing of which is punishable by law. The most technical mode of doing this, is to preface the recital of the instrument by the words “ to the tenor following;” but equivalent terms, such as “ in these words,” or “ as follows,” or “ in .the words and figures following,” will do. 1 Chitt. C. L. 234, — 3 id. 1040. — 1 East, 180. Purport, however, has a signification different from tenor; it means the *substance*as it appears on the face of the instrument; *tenor*imports an exact copy. 1 Chitt. C. L. 235. — 2 East, C. L. 983. The indictment in question is defective in professing to set out the effect, purport, or substance only of the fictitious bills.

*Per Curiam.*

The judgment is affirmed.
**EXHIBIT      10.3**

**AMENDMENT      TO**

**DISTRIBUTION      AGREEMENT**

**Dated      February 7, 2002**

**This      Amendment No. 1**
**Medi-Hut      Co., Inc.**
**Syntho      Pharmaceuticals, Inc.**

**RECITALS**

|   | A. | Medi                and Syntho executed and delivered a Distribution Agreement dated                as of                November 20, 2001 (the “Agreement”) pursuant to which Medi agreed to                exclusively distribute Subject Technology (as defined in paragraph                1.1 of                the Agreement) and Syntho agreed to manufacture Subject                Technology. |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | B. | The                Parties desire to amend the Agreement in the particulars set forth                in                paragraph 4.1 of the Agreement. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------|

**NOW,      THEREFORE,**

**IN      WITNESS WHEREOF,**

|                                     |                                        |                                      |
|------------------------------------------|---------------------------------------------|-------------------------------------------|
|                                     | **MEDI-HUT              CO., INC.**         |
|                                |                                   |                                 |
| Date: February              7, 2002 | By:                               | /s/ Joseph              A. Sanpietro |
|                                     |                                             |
|                                     | Joseph              A. Sanpietro, President |

|                                       |                                            |                                   |
|--------------------------------------------|-------------------------------------------------|----------------------------------------|
|                                       |                                            |
|                                       | **SYNTHO                PHARMACEUTICALS, INC.** |
|                                  |                                       |                              |
| Date: February                7, 2002 | By:                                   | /s/ Muhammed                Malik |
|                                       |                                                 |
|                                       | Muhammed                Malik, President        |

----
H. Res. 29 

In the House of Representatives, U. S., 

January 6, 2017. 

Resolved, That the following named Members be, and are 

hereby, elected to the following standing committees of the 

House of Representatives: 

COMMITTEE ON APPROPRIATIONS: Mr. Rogers of Kentucky, Mr. Aderholt, Ms. Granger, Mr. Simpson, Mr. Culberson, Mr. Carter of Texas, Mr. Calvert, Mr. Cole, Mr. DiazBalart, Mr. Dent, Mr. Graves of Georgia, Mr. Yoder, Mr. 

Womack, Mr. Fortenberry, Mr. Thomas J. Rooney of Florida, Mr. Fleischmann, Ms. Beutler, Mr. Joyce of Ohio, Mr. 

Valadao, Mr. Harris, Mrs. Roby, Mr. Amodei, Mr. Stewart, 

Mr. Young of Iowa, Mr. Jenkins of West Virginia, Mr. 

Palazzo, Mr. Newhouse, Mr. Moolenaar, and Mr. Taylor. 

COMMITTEE ON ENERGY AND COMMERCE: Mr. Barton, 

Mr. Upton, Mr. Shimkus, Mr. Murphy of Pennsylvania, Mr. 

Burgess, Mrs. Blackburn, Mr. Scalise, Mr. Latta, Mrs. 

McMorris Rodgers, Mr. Harper, Mr. Lance, Mr. Guthrie, Mr. 

Olson, Mr. McKinley, Mr. Kinzinger, Mr. Griffith, Mr. Bilirakis, Mr. Johnson of Ohio, Mr. Long, Mr. Bucshon, Mr. 
2 

•HRES 29 EH 

Flores, Mrs. Brooks of Indiana, Mr. Mullin, Mr. Hudson, Mr. 

Collins of New York, Mr. Cramer, Mr. Walberg, Mrs. Mimi 

Walters of California, Mr. Costello of Pennsylvania, and Mr. 

Carter of Georgia. 

COMMITTEE ON FINANCIAL SERVICES: Mr. King of New 

York, Mr. Royce of California, Mr. Lucas, Mr. McHenry, Mr. 

Pearce, Mr. Posey, Mr. Luetkemeyer, Mr. Huizenga, Mr. 

Duffy, Mr. Stivers, Mr. Hultgren, Mr. Ross, Mr. Pittenger, 

Mrs. Wagner, Mr. Barr, Mr. Rothfus, Mr. Messer, Mr. Tipton, Mr. Williams, Mr. Poliquin, Mrs. Love, Mr. Hill, Mr. 

Emmer, Mr. Zeldin, Mr. Trott, Mr. Loudermilk, Mr. Mooney 

of West Virginia, Mr. MacArthur, Mr. Davidson, Mr. Budd, 

Mr. Kustoff, Ms. Tenney, and Mr. Hollingsworth. 

COMMITTEE OF WAYS AND MEANS: Mr. Sam Johnson of 

Texas, Mr. Nunes, Mr. Tiberi, Mr. Reichert, Mr. Roskam, 

Mr. Tom Price of Georgia, Mr. Buchanan, Mr. Smith of Nebraska, Ms. Jenkins of Kansas, Mr. Paulsen, Mr. Marchant, 

Mrs. Black, Mr. Reed, Mr. Kelly of Pennsylvania, Mr. 

Renacci, Mr. Meehan, Mrs. Noem, Mr. Holding, Mr. Smith 

of Missouri, Mr. Tom Rice of South Carolina, Mr. 

Schweikert, Mrs. Walorski, and Mr. Curbelo of Florida. 

Attest: 

Clerk.
NAC Tracking Number 2010-04-07 (EC-03) 

Developing Operability Incentives When Acquiring Commercial Crew Capabilities 

NASA Advisory Council Recommendation: 


NASA should develop operability incentives for the acquisition of commercial crew capabilities. 


These incentives should drive commercial partner design to include features resulting in 


recurring cost ofoperations low enough to attract other customers in addition to NASA. 


NASA Response: 


NASA concurs. NASA's commercial crew program strategy includes several features that 


incentivize cost-effective recurring operations for all customers, including the Government. 


First, NASA will impose only the minimum set ofrequirements on commercial partners to 


ensure safety while enabling innovative and cost-effective design solutions. Second, NASA will 


require the commercial partners to share in the cost ofthe design and development of 


commercial crew capabilities, which will encourage the commercial partners to minimize costs 


and acquire other customers in order to get a return on its investment. Third, NASA will strive 


for competition among multiple commercial partners throughout the design, development, test, 


evaluation, and certification phase and, ideally, through the award ofany service to ISS, which is 


the predominant incentive to minimize operations costs. Note: The ability to fund multiple 


commercial partners will be based on available budget. 


Enclosure I
Order entered October 6 , 2022

In The 

### Court of Appeals Fifth District of Texas at Dallas
No. 05
- 2 1
- 00 827
- CR No. 05
- 2 1
- 00 828
- CR
PRESTON OLIN BURKLEY , Appellant

V. THE STATE OF TEXAS , Appellee
On A ppeal from the 203rd Judicial District Court

Dallas County, Texas Trial Court Cause No s . F20
- 40748
- P & F20
- 40749
- P

O RDER This appeal was set for oral argument on September 27, 2022, and counsel for appellant and the State were present. Before argument, appellant’s counsel apprised the Court that he had to attend to a medical emergency. Thereafter, the Justices on the panel conferred off the record and determined that oral argument would not significantly aid them in determining the legal and factual iss ues presented in the appeal.Accordingly, we ORDER the appeal submitted without oral argument on

September 27, 2022.

/s/ CRAIG SMITH JUSTICE
1 min read

# Station Station Environmental Control and Life Support Systems

### Space Station Research Integration Office

Dec 01, 2021

Article

            -   
            -   
            -   
            -   

## Contents

              -  Fact Sheet 
              -  Infographic 

## Fact Sheet

Environmental Control and Life Support Systems (PDF)

## Infographic

*NASA*

## Discover More Topics

Space Station Technology Demonstration

Opportunities and Information for Researchers

In Space Production Applications

Latest News from Space Station Research
WILLIAM HAKIM BENTLEY

,

Appellant,

v.

STATE OF FLORIDA

,

Appellee. IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

CASE NO. 1D 16-2979

_____________________________/

Opinion filed January 30

, 2017.

An appeal from the Circuit Court for Okaloosa County

. John T. Brown

, Judge.

Andy Thomas, Public Defender, and Lori A. Willner, Assistant Public Defender,

Tallahassee

, for Appellant.

Pamela Jo Bondi, Attorney General, Jason W. Rodriguez, Assistant Attorney

General, and Angela R. Hensel, Assistant Attorney General, Tallahassee

, for

Appellee.

PER CURIAM.

AFFIRMED.

OSTERHAUS

, JAY

, and WINSOR

, JJ., CONCUR.
<TABLE> <S> <C>


<ARTICLE>                     5


<S>                             <C>                      <C>
<PERIOD-TYPE>                   YEAR                     YEAR
<FISCAL-YEAR-END>                       AUG-31-2000              AUG-31-1999
<PERIOD-START>                          SEP-01-1999              SEP-01-1998
<PERIOD-END>                            AUG-31-2000              AUG-31-1999
<CASH>                                            0                  514,000
<SECURITIES>                                      0                        0
<RECEIVABLES>                               470,000                   66,000
<ALLOWANCES>                                219,000                    2,000
<INVENTORY>                                       0                        0
<CURRENT-ASSETS>                            369,000                  621,000
<PP&E>                                      300,000                  278,000
<DEPRECIATION>                              128,000                   94,000
<TOTAL-ASSETS>                              177,000                  342,000
<CURRENT-LIABILITIES>                       593,000                  200,000
<BONDS>                                           0                        0
<PREFERRED-MANDATORY>                       182,228                  182,228
<PREFERRED>                                       0                        0
<COMMON>                                  1,324,651                1,324,651
<OTHER-SE>                               (2,025,845)                (634,362)
<TOTAL-LIABILITY-AND-EQUITY>                718,000                1,147,000
<SALES>                                     820,000                  958,000
<TOTAL-REVENUES>                            820,000                  958,000
<CGS>                                     1,055,000                  920,000
<TOTAL-COSTS>                             2,385,000                1,828,000
<OTHER-EXPENSES>                                  0                        0
<LOSS-PROVISION>                                  0                        0
<INTEREST-EXPENSE>                                0                        0
<INCOME-PRETAX>                          (1,079,000)                (482,000)
<INCOME-TAX>                                 (5,000)                   1,000
<INCOME-CONTINUING>                               0                        0
<DISCONTINUED>                                    0                        0
<EXTRAORDINARY>                                   0                        0
<CHANGES>                                         0                        0
<NET-INCOME>                             (1,083,000)                (481,000)
<EPS-BASIC>                                   (0.11)                   (0.05)
<EPS-DILUTED>                                 (0.08)                   (0.03)



</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1997
<PERIOD-START>                             OCT-01-1996
<PERIOD-END>                               DEC-31-1997
<CASH>                                       1,046,857
<SECURITIES>                                         0
<RECEIVABLES>                                1,164,060
<ALLOWANCES>                                         0
<INVENTORY>                                 84,954,929
<CURRENT-ASSETS>                            87,165,846
<PP&E>                                       1,242,902
<DEPRECIATION>                                 641,247
<TOTAL-ASSETS>                              90,826,219
<CURRENT-LIABILITIES>                       28,914,098
<BONDS>                                     34,553,499
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       137,578
<OTHER-SE>                                  27,221,044
<TOTAL-LIABILITY-AND-EQUITY>                90,826,219
<SALES>                                     49,613,944
<TOTAL-REVENUES>                            49,613,944
<CGS>                                       43,201,588
<TOTAL-COSTS>                               43,201,588
<OTHER-EXPENSES>                             4,770,184
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             262,954
<INCOME-PRETAX>                              1,420,820
<INCOME-TAX>                                   598,000
<INCOME-CONTINUING>                            822,820
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   822,820
<EPS-PRIMARY>                                      .15
<EPS-DILUTED>                                      .15
        

</TABLE>
EXHIBIT 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of DrugMax, Inc. (the Company) on Form 10-Q for the period ended September 30, 2004, as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Ronald J. Patrick, Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002,
that to my knowledge:



(1) The Report fully complies with requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The
information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



/s/ Ronald J. PatrickRonald J. PatrickChief Financial Officer,Principal Financial and Accounting OfficerNovember 10, 2004
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
BOOKS-A-MILLION, INC. CONSOLIDATED BALANCE SHEETS, CONSOLIDATED STATEMENTS OF
INCOME AND CONSOLIDATED STATEMENTS OF CASH FLOWS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FORM 10-Q FOR THE QUARTERLY PERIOD ENDED NOVEMBER
2, 1996.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          FEB-01-1997
<PERIOD-START>                             FEB-04-1996
<PERIOD-END>                               NOV-02-1996
<EXCHANGE-RATE>                                      1
<CASH>                                           4,281
<SECURITIES>                                         0
<RECEIVABLES>                                   22,248
<ALLOWANCES>                                         0
<INVENTORY>                                    151,689
<CURRENT-ASSETS>                               182,346<F1>
<PP&E>                                          82,844
<DEPRECIATION>                                  25,342
<TOTAL-ASSETS>                                 241,499<F2>
<CURRENT-LIABILITIES>                          110,861
<BONDS>                                              0<F3>
<PREFERRED-MANDATORY>                                0<F4>
<PREFERRED>                                          0
<COMMON>                                           174
<OTHER-SE>                                      91,946
<TOTAL-LIABILITY-AND-EQUITY>                   241,499
<SALES>                                        181,549
<TOTAL-REVENUES>                               181,549
<CGS>                                          135,602
<TOTAL-COSTS>                                  170,325
<OTHER-EXPENSES>                                 6,876
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,912
<INCOME-PRETAX>                                  2,436
<INCOME-TAX>                                       926
<INCOME-CONTINUING>                              1,510
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,510
<EPS-PRIMARY>                                     0.09
<EPS-DILUTED>                                     0.09
<FN>
<F1>OTHER CURRENT ASSETS - 4,128
<F2>OTHER ASSETS - 1,651
<F3>LONG TERM DEBT - 37,255
<F4>DEFERRED INCOME TAXES - 1,263
</FN>
        

</TABLE>